The global GMP Cytokines Market is experiencing significant expansion, driven by increasing demand for high-quality cytokines in advanced therapies such as cell and gene therapy. According to The Insight Partners, the market was valued at US$ 128.7 million in 2023 and is projected to reach US$ 350.2 million by 2031, registering a robust CAGR of 9.7% during the forecast period (2023–2031)....